Sexually Transmitted Disease Treatment and Vaccines Remain Underwhelming - Precision Vaccinations
Houston (Precision Vaccinations) The U.S. Sexually Transmitted Infections (STI) National Strategic Plan includes, but is not limited to, vaccine and treatment research focused on chlamydia, gonorrhea, and Mpox. According to recent STI reports, additional clinical evaluations and research are needed for these diseases. For example, the U.S. Centers for Disease Control and Prevention (CDC) today announced a report describing New York City patients with Mpox who developed new lesions after completing oral treatment. This CDC report suggests that post-treatment lesions might occur more commonly than previously reported. During the 2022 Mpox outbreak in the U.S., TPOXX® (tecovirimat), an antiviral medication approved for the treatment of smallpox, was used as an investigational treatment for severe mpox. However, efficacy and optimal treatment duration are still being investigated in 2023. All ten patients received outpatient treatment from the...